Moderna, Inc. (MRNA)
NASDAQ: MRNA · IEX Real-Time Price · USD
111.46
+1.15 (1.04%)
At close: May 1, 2024, 4:00 PM
112.30
+0.84 (0.75%)
After-hours: May 1, 2024, 7:25 PM EDT

Moderna Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019201820172016
Market Capitalization
42,67637,91969,006102,97641,3406,5184,954--
Market Cap Growth
--45.05%-32.99%149.10%534.20%31.58%---
Enterprise Value
35,30530,53360,10892,95436,9395,5473,465-741-1,046
PE Ratio
-8.04-8.048.258.44-55.34-12.68-12.33--
PS Ratio
6.235.543.585.5851.48108.6436.68--
PB Ratio
3.082.743.617.2816.145.553.24--
P/FCF Ratio
-9.91-9.9115.067.7221.10-13.28-11.35--
P/OCF Ratio
-12.16-12.1613.857.5620.39-14.20-14.97--
EV/Sales Ratio
5.164.463.125.0346.0092.4525.66-3.60-9.65
EV/EBITDA Ratio
-9.19-9.196.066.88-56.74-11.46-9.643.155.23
EV/EBIT Ratio
-7.75-7.756.287.00-49.65-10.77-9.012.904.86
EV/FCF Ratio
-7.98-7.9813.126.9718.86-11.30-7.941.90-31.13
Debt / Equity Ratio
0.090.090.050.050.080.110.02-0.03-0.04
Debt / EBITDA Ratio
-0.37-0.370.100.05-0.32-0.27-0.09-0.07-0.06
Debt / FCF Ratio
-0.32-0.320.220.050.11-0.27-0.08-0.040.37
Quick Ratio
3.153.152.291.521.377.756.894.026.58
Current Ratio
3.433.432.731.761.447.897.024.096.68
Asset Turnover
0.330.330.730.990.180.040.090.17-
Return on Equity (ROE)
-29.90%-29.90%46.30%140.20%-30.20%-39.50%-82.10%60.90%-
Return on Assets (ROA)
-22.50%-22.50%31.70%65.60%-17.00%-30.80%-26.40%-21.60%-
Return on Capital (ROIC)
-28.13%-28.13%40.87%82.24%-27.57%-41.77%-26.43%50.28%69.43%
Earnings Yield
-11.04%-12.43%12.12%11.85%-1.81%-7.89%-8.11%--
FCF Yield
-8.96%-10.09%6.64%12.95%4.74%-7.53%-8.81%--
Buyback Yield / Dilution
8.17%8.17%3.48%-13.12%-15.11%-308.07%-25.76%-6.17%-
Total Shareholder Return
8.17%8.17%3.48%-13.12%-15.11%-308.07%-25.76%-6.17%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).